Literature DB >> 1762285

Racial differences in the incidence and progression of renal diseases.

S R Smith, L P Svetkey, V W Dennis.   

Abstract

There is an excess incidence of ESRD treatment among non-White North Americans that is not completely explained by the racial prevalences of the underlying diseases, including hypertension, which can potentially cause renal disease. The racial difference is particularly striking for presumed nephrosclerosis from hypertension and for nephropathy from Type II diabetes, but is not yet substantiated for ESRD attributed to polycystic kidney disease or Type I diabetes. The existing data are insufficient to support the notion that poorer blood pressure control alone is responsible for the racial differences in incident ESRD. Black race (and possibly Mexican or Native American heritage) may be a specific risk factor for ESRD, independent of hypertension and its treatment.

Entities:  

Mesh:

Year:  1991        PMID: 1762285     DOI: 10.1038/ki.1991.281

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  18 in total

1.  Rationing: at the cutting edge.

Authors:  V Parsons
Journal:  BMJ       Date:  1991-12-14

2.  A comparison of the effects of the selective peripheral alpha 1-blocker terazosin with the selective beta 1-blocker atenolol on blood pressure, exercise performance and the lipid profile in mild-to-moderate essential hypertension.

Authors:  M Ligueros; R Unwin; M R Wilkins; J Humphreys; S J Coles; J Cleland
Journal:  Clin Auton Res       Date:  1992-12       Impact factor: 4.435

Review 3.  Principles of drug administration in renal insufficiency.

Authors:  Y W Lam; S Banerji; C Hatfield; R L Talbert
Journal:  Clin Pharmacokinet       Date:  1997-01       Impact factor: 6.447

4.  Type 2 diabetes: identifying high risk Asian American subgroups in a clinical population.

Authors:  Elsie J Wang; Eric C Wong; Anjali A Dixit; Stephen P Fortmann; Randolph B Linde; Latha P Palaniappan
Journal:  Diabetes Res Clin Pract       Date:  2011-06-12       Impact factor: 5.602

5.  Diabetes mellitus and its complications in an African-American community: project DIRECT.

Authors:  W H Herman; T J Thompson; W Visscher; R E Aubert; M M Engelgau; L Liburd; D J Watson; T Hartwell
Journal:  J Natl Med Assoc       Date:  1998-03       Impact factor: 1.798

6.  Rapid progression to end-stage renal disease in young hypertensive African Americans with proteinuria.

Authors:  C I Obialo; K Hewan-Lowe
Journal:  J Natl Med Assoc       Date:  1998-11       Impact factor: 1.798

7.  Markedly increased renal disease mortality and incidence of renal replacement therapy among IDDM patients in Japan in contrast to Allegheny County, Pennsylvania, USA. Diabetes Epidemiology Research International (DERI) U.S.-Japan Mortality Study Group.

Authors:  M Matsushima; N Tajima; R E LaPorte; T J Orchard; E S Tull; I F Gower; T Kitagawa
Journal:  Diabetologia       Date:  1995-02       Impact factor: 10.122

8.  A project to reduce the burden of diabetes in the African-American Community: Project DIRECT.

Authors:  M M Engelgau; K M Narayan; L S Geiss; T J Thompson; G L Beckles; L Lopez; T Hartwell; W Visscher; L Liburd
Journal:  J Natl Med Assoc       Date:  1998-10       Impact factor: 1.798

9.  Racial differences in the effect of a telephone-delivered hypertension disease management program.

Authors:  George L Jackson; Eugene Z Oddone; Maren K Olsen; Benjamin J Powers; Janet M Grubber; Felicia McCant; Hayden B Bosworth
Journal:  J Gen Intern Med       Date:  2012-08-03       Impact factor: 5.128

Review 10.  Hypertension-attributed nephropathy: what's in a name?

Authors:  Barry I Freedman; Arthur H Cohen
Journal:  Nat Rev Nephrol       Date:  2015-11-10       Impact factor: 28.314

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.